Bristol-Myers Squibb

BMY13F as of Jun 30, 2026 · next update ~Nov 14

Who's buying BMY

Top funds were split on Bristol-Myers Squibb in Q2 (Apr⁠–⁠Jun)

Buying:

FundsInsidersCongress

Top funds
3 of 8 bought more, 4 sold some. Largest: Pzena Investment Management, $979.9M (3% of its portfolio).
Insiders
No buys, 3 sales in 12 months.
Congress
1 member bought (1 trade), 2 sales in 12 months.

8 funds$1.0B held1.0% avg. weightQ2: 3 bought / 4 sold

13F reports are a snapshot as of Jun 30, 2026; funds may have traded since. Insiders often sell for personal reasons (taxes, diversification, planned sales).

Share price · market data, not from 13F reports

Q2 2026

Insider trades (Form 4)

Last 2 years · 10 filings

Net buying$5.41M

Date	Insider	Type	Shares	Price	Value
Sep 9, 2026	Cristian Massacesi VP	Sold	6,249	$64.57	$403K
Aug 25, 2026	Phil M Holzer VP & Controller	Sold	500	$67.50	$34K
Apr 1, 2026	David V Elkins VP & CFO	Sold	30,000	$61.67	$1.85M
Sep 2, 2025	David V Elkins VP & CFO	Sold	56,000	$47.33	$2.65M
Aug 2, 2025	Bartie Wendy Short VP	Sold	378	$44.23	$17K
May 9, 2025	Benjamin Hickey President	Sold	97	$38.01	$4K
Apr 25, 2025	Samit Hirawat VP	Bought	4,250	$47.58	$202K
Feb 20, 2025	Christopher S. Boerner CEO	Bought	2,000	$55.05	$110K
Feb 14, 2025	Samit Hirawat VP	Bought	1,823	$54.84	$100K
Nov 4, 2024	Phil M Holzer VP & Controller	Sold	700	$55.62	$39K